GURUFOCUS.COM » STOCK LIST » Utilities » Utilities - Independent Power Producers » Orion Pharma Ltd (DHA:ORIONPHARM) » Definitions » Gross Profit

Orion Pharma (DHA:ORIONPHARM) Gross Profit : BDT2,148 Mil (TTM As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Orion Pharma Gross Profit?

Orion Pharma's gross profit for the three months ended in Sep. 2024 was BDT449 Mil. Orion Pharma's gross profit for the trailing twelve months (TTM) ended in Sep. 2024 was BDT2,148 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Orion Pharma's gross profit for the three months ended in Sep. 2024 was BDT449 Mil. Orion Pharma's Revenue for the three months ended in Sep. 2024 was BDT1,647 Mil. Therefore, Orion Pharma's Gross Margin % for the quarter that ended in Sep. 2024 was 27.25%.

Orion Pharma had a gross margin of 27.25% for the quarter that ended in Sep. 2024 => Competition eroding margins

During the past 12 years, the highest Gross Margin % of Orion Pharma was 33.71%. The lowest was 16.37%. And the median was 25.29%.

Warning Sign:

Orion Pharma Ltd gross margin has been in long-term decline. The average rate of decline per year is -10.6%.


Orion Pharma Gross Profit Historical Data

The historical data trend for Orion Pharma's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Pharma Gross Profit Chart

Orion Pharma Annual Data
Trend Dec14 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,577.84 2,739.52 1,974.20 2,280.17 2,287.07

Orion Pharma Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 588.17 622.77 515.23 560.90 448.71

Competitive Comparison of Orion Pharma's Gross Profit

For the Utilities - Independent Power Producers subindustry, Orion Pharma's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orion Pharma's Gross Profit Distribution in the Utilities - Independent Power Producers Industry

For the Utilities - Independent Power Producers industry and Utilities sector, Orion Pharma's Gross Profit distribution charts can be found below:

* The bar in red indicates where Orion Pharma's Gross Profit falls into.



Orion Pharma Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Orion Pharma's Gross Profit for the fiscal year that ended in Jun. 2024 is calculated as

Gross Profit (A: Jun. 2024 )=Revenue - Cost of Goods Sold
=10620.866 - 8333.796
=2,287

Orion Pharma's Gross Profit for the quarter that ended in Sep. 2024 is calculated as

Gross Profit (Q: Sep. 2024 )=Revenue - Cost of Goods Sold
=1646.542 - 1197.832
=449

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT2,148 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Orion Pharma's Gross Margin % for the quarter that ended in Sep. 2024 is calculated as

Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=449 / 1646.542
=27.25 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Orion Pharma  (DHA:ORIONPHARM) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Orion Pharma had a gross margin of 27.25% for the quarter that ended in Sep. 2024 => Competition eroding margins


Orion Pharma Gross Profit Related Terms

Thank you for viewing the detailed overview of Orion Pharma's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Orion Pharma Business Description

Traded in Other Exchanges
N/A
Address
153-154 Tejgaon Industrial Area, Dhaka, BGD, 1208
Orion Pharma Ltd is a pharmaceutical company engaged in the manufacturing and marketing of pharmaceutical drugs and medicines. It provides its drugs in various dosage forms including tablet, capsule, syrup, suspension, injection, dry powder for syrup and suspension, for therapeutic groups like anticancer, antibiotics, antidiabetics, anxiolytics, diuretics, cardiovascular drugs, and others. In addition, the company is also involved in power generation activities. It generates maximum revenue from power generation activities. The group principally carries out its business operations and markets its products in Bangladesh.

Orion Pharma Headlines

No Headlines